Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersGynecologic Oncology Physician in Knoxville, TN
NPI: 1235457151Primary Practice Location
UNIVERSITY HEALTH SYSTEM, INC
1924 Alcoa Hwy, Knoxville, TN
Primary Employer
University Pathologists, P.C.
utmedicalcenter.org
HQ Phone
Get M.D. Jonathan's Phone Numberphone_androidMobile
Get M.D. Jonathan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTN State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 72 | 100 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 52 | 166 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 34 | 34 |
| 4 | 58571Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | 21 | 21 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 16 | 77 |
Targeting the Wnt/β-catenin pathway in primary ovarian cancer with the porcupine inhibitor WNT974.
Authors: Rebecca Arend, John Straughn
Water only fasting and its effect on chemotherapy administration in gynecologic malignancies.
Lead Sponsor: Karyopharm Therapeutics Inc
Collaborators: Belgian Gynaecological Oncology Group, GOG Foundation, Israeli Society of Gynecologic Oncology, Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies, Spanish Research Group in Ovarian Cancer, The Central and Eastern European Gynecologic Oncology Group, North-Eastern German Society of Gynaecologic Oncology
Intervention / Treatment: DRUG: Selinexor, DRUG: Matching placebo for selinexor
Lead Sponsor: Tesaro, Inc.
Collaborators: European Network of Gynaecological Oncological Trial Groups (ENGOT), GOG Foundation
Intervention / Treatment: DRUG: Carboplatin, DRUG: Niraparib, DRUG: Paclitaxel, BIOLOGICAL: Dostarlimab, DRUG: Placebo matching Niraparib, DRUG: Placebo matching dostarlimab
